Industry NewsClinical Diagnostics Thermo Fisher Scientific utilizes NGS technology to advance myeloid cancer research and treatment
Product NewsLife Sciences FDA Approval for CliniMACS® CD34 Reagent System for Prevention of Graft-Versus-Host Disease in the Treatment of Acute Myeloid Leukemia
Myeloid Lineage Abnormalities – A Journey into the World of Myeloid Diseases with Cutting-Edge Flow Cytometry TechnologyAvailable on-demand
